Condition: Lung Cancer Squamous Cell · COPD · Sponsor: Guangzhou Institute of Respiratory Disease
To evaluate the efficacy and safety of inhaled corticosteroids combined with bronchodilators and programmed death-ligand 1 (PD-L1) inhibitor plus platinum-based chemotherapy in patients with advanced lung squamous cell carcinoma complicated with chronic obstructive pulmonary disease (COPD)
This description comes directly from the study's public registry record.
ZHOU · 13560351186 · doctorzcz@163.com
Always discuss trial participation with your own doctor first.
| NO.28 Qiaozhong Zhong Road, Liwan District, Guangzhou City, Guangdong Province | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06772454